- Research article
- Open Access
Fragile X astrocytes induce developmental delays in dendrite maturation and synaptic protein expression
© Jacobs et al; licensee BioMed Central Ltd. 2010
- Received: 19 May 2010
- Accepted: 18 October 2010
- Published: 18 October 2010
Fragile X syndrome is the most common inherited form of mental impairment characterized by cognitive impairment, attention deficit and autistic behaviours. The mouse model of Fragile X is used to study the underlying neurobiology associated with behavioral deficiencies. The effect of Fragile X glial cells on the development of neurons has not been studied. We used a co-culture technique in combination with morphometrics on immunostained neurons to investigate the role of astrocytes in the development delays associated with hippocampal neuron development.
We found that hippocampal neurons grown on Fragile X astrocytes exhibited a significant difference from the neurons grown with normal astrocytes after 7 days in vitro for many parameters including increases in dendritic branching and in area of the cell body. However, after 21 days in culture, the neurons grown on Fragile X astrocytes exhibited morphological characteristics that did not differ significantly from the neurons grown on normal astrocytes. With antibodies to the pre-synaptic protein, synapsin, and to the excitatory post-synaptic protein, PSD-95, we quantified the number of developing excitatory synapses on the dendrites. In addition to the delays in dendritic patterning, the development of excitatory synapses was also delayed in the hippocampal neurons.
These experiments are the first to establish a role for astrocytes in the delayed growth characteristics and abnormal morphological features in dendrites and synapses that characterize the Fragile X syndrome.
- Hippocampal Neuron
- Dendritic Arbor
- Excitatory Synapse
- Primary Hippocampal Neuron
- Dendritic Spine Morphology
As the central nervous system (CNS) develops numerous events must occur in a highly regulated manner to create the intricate organization of neural networks that control the mature brain. One of the key players recognized in the guidance of neuron development is the astrocyte [1–5]. As such, abnormal or 'diseased' astrocytes are now known to be prominent factors in the neurobiology of a number of developmental diseases of the CNS including Fragile X Syndrome (FXS) [3, 6–8].
FXS is the most common inherited form of mental retardation, affecting approximately 1/2500 children . Children with FXS suffer from a number of behavioural deficiencies including: mild to severe cognitive impairment, hyperactivity, attention deficit, susceptibility to seizures, motor disorders and autistic behaviours . Underlying neurobiological abnormalities in FXS are recognized in the form of altered dendritic growth, abundant immature dendritic spines and inappropriate synaptic development [11–13]. The defects in individuals with FXS can be attributed to a mutation in the Fragile X Mental Retardation 1 (FMR1) gene causing gene silencing and a lack of the protein product, Fragile X Mental Retardation Protein (FMRP) .
The Fmr1 knockout (-/-) mouse model of FXS is well accepted as an appropriate model in which to study the neurobiology of FXS . The Fmr1-/- mouse has been shown to demonstrate behavioural qualities similar to those seen in individuals with FXS, including: susceptibility to seizures, hyperactivity and learning impairments [15–17]. Additionally, the neurons of Fmr1-/- show similarly abnormal dendritic spine morphology and altered synaptic function [18, 19], as documented in humans with FXS .
Contrary to the current belief that FMRP is only expressed in neurons, recent work in our lab revealed that FMRP is also expressed in cells of the glial lineage in the Fmr1-/- mouse . Based on these findings we began our investigation into the role of astrocytes in the development of the abnormal neurobiology of FXS. Previously, we used the Fmr1-/- mouse model to investigate the role of astrocytes in the development of the abnormal neuronal characteristics seen in FXS . In short, we found that Fragile X astrocytes were not able to support normal neuron growth and contributed to the abnormal neuronal phenotype seen in the Fragile X mouse. However, in that series of experiments, we focused on the early development of neurons, solely evaluating the effect of null astrocytes on the neurons after seven days in culture. Given that FXS is a developmental disorder, we wondered if neurons were prevented from normal maturation when exposed to signaling from the Fragile X astrocytes. If so, is it possible that neurons exposed to Fragile X astrocytes could recover from developmental delays? If true, this information would foster insight into the potential for astrocyte-directed therapeutic interventions as a preventative measure against the neuronal abnormalities underlying FXS. Such is the basis for the following experiments in which we investigated the possibility of an astrocyte-mediated a delay in neuron development using detailed morphometric and synaptic protein analyses combined with immunocytochemistry.
The FMRP knock-out FVB.129P2(B6)-Fmr1 tm1Cgr  and wild-type (WT) mice used for these experiments were housed and bred at the McMaster University Central Animal Facility. All experiments were completed in accordance with the guidelines set out by the Canadian Council on Animal Care and were approved by the McMaster Animal Research Ethics Board.
Primary hippocampal neurons with astrocytes were grown in co-culture conditions as detailed previously by our lab . Briefly, cortical astrocytes were isolated from post-natal day (PND) 0-1 pups and grown on Poly-L-Lysine (1 mg/ml, Cat. No. P1399, SIGMA-ALDRICH, Oakville, Canada) and Laminin (0.1 mg/ml, Cat. No. 23017-015, Invitrogen, Burlington, Canada) coated coverslips in MEM (Cat No. 11095-080, Invitrogen, Burlington, Canada) supplemented with 6% glucose and 10% horse serum (Cat No. 16050-122, Invitrogen, Burlington, Canada), for one week. Primary hippocampal neurons were then isolated from embryonic day 17 (day of sperm plug counted as PND1) animals and seeded above the astrocytes and maintained in MEM supplemented with N2 (Cat No. 17502-048, Invitrogen, Burlington, Canada), sodium pyruvate (Cat No. 11360-070, Invitrogen, Burlington, Canada) and 6% glucose, for the duration of the experiments. Hippocampal neurons isolated from WT animals were grown with astrocytes, from either WT or Fmr1-/- mice, in culture for 7, 14 or 21 days. These cultures were grown in culture for 7, 14 or 21 days. A total of three independent cultures per condition (genotype+days in vitro (DIV)) were completed.
Following removal of the media, the cells were fixed with 4% PFA in PBS or ice cold (-20°C) acetone for 15 or 20 minutes, respectively. After three washes with PBS, and the application of 0.1% Triton X-100 where necessary, non-specific binding was blocked with 1% bovine serum albumin (BSA) for 30 minutes. Primary antibodies were applied to the coverslips and incubated overnight at 4°C. The second day, following washes with PBS, secondary antibodies were incubated with the cells for 3 hours at room temperature. Following a final set of washes with PBS and distilled water, the coverslips were mounted onto slides with Vectashield fluorescent mounting medium (Vector Labs, Burlington, Canada) containing DAPI to stain the nuclei.
The following antibodies, diluted in 1% BSA, were used: chicken anti-Map2 (Microtubule Associated Protein -2, 1:20,000, Neuromics, Edina, MN), guinea pig anti-synapsin (1:1000, Synaptic Systems, Goettingen, Germany), mouse monoclonal anti-PSD-95 (Post-Synaptic Density protein-95, Clone 6G6-1C9, 1:200, Millipore, Temecula, CA), anti-mouse AlexaFluor 594 (1:1500, Invitrogen, Burlington, Canada), anti-guinea pig FITC (1:200, Jackson ImmunoResearch, West Grove, PA) and anti-chicken FITC (1:100, Jackson ImmunoResearch, West Grove, PA).
Images were acquired using a Zeiss Axioskop 2 epi-fluorescence microscope and Axiovision (v4.6) image acquisition software.
Dendritic arbor morphology
Cell body measurements
For each of the above neurons the area of the cell body was also measured, by tracing around the cell body using Image J.
Synaptic puncta analysis
Synapses were identified by the co-localization of the pre- (synapsin) and post-synaptic (PSD-95) puncta, using a custom written plug-in for Image . After selecting a 50 μm segment along the dendrite, the image was processed using the above plug-in. Briefly, low frequency background from each channel (red and green) of the image was removed with the rolling ball background subtraction algorithm. Then, the puncta in each single-channel was 'masked' by thresholding the image so that only puncta remained above threshold. Puncta were then identified in each channel by the "Particle Analyzer" plug-in for Image J. Co-localization of the puncta in each channel was indentified when the distance between the centers of the two puncta was less than the radius of the larger puncta. The number of co-localized puncta was then recorded as synapses. For each independent culture one hundred 50 μm-long sections along the dendrites were evaluated for synaptic protein expression.
Statistics were performed using SPSS version 17, with an alpha level set to 0.05. All data are presented as mean ± SEM. Where the data had significantly different variances (as determined by Levene's test for equal variances), and deviated significantly from a normal distribution (as determined by the Shapiro-Wilk test for normality, Mann-Whitney U (two-tailed) tests were used.
The length of the longest dendrite was also significantly different at 7 DIV. At 7 DIV, neurons grown on Fmr1-/- astrocytes exhibited significantly (p = 0.019; Mann Whitney U = 9491.00; F = -2.342) lower values (148.93 ± 6.47) of their longest dendrites compared to neurons grown on WT astrocytes (167.40 ± 6.47)(Figure 4b). The length of the longest dendrite increased at 14 DIV, and decreased slightly at 21 DIV, for neurons grown on both Fmr1-/- and WT astrocytes. No significant difference in length of the longest dendrite was observed at 14 DIV (Fmr1-/-, 295.94 ± 16.00; WT, 338.86 ± 21.14; p = 0.261; Mann Whitney U = 10335.00; F = -1.124) or 21 DIV (Fmr1-/-, 263.78 ± 12.29; WT, 274.78 ± 11.97; p = 0.229, Mann Whitney U = 10205.00; F = -1.203).
At 7 DIV, but not 14 or 21 DIV, the cell body area was significantly (p = 0.047; Mann Whitney U = 9754.50; F = -1.991) increased in neurons grown on Fmr1-/- astrocytes (197.10 ± 5.87) compared to those grown on WT astrocytes (179.85 ± 3.95)(Figure 4c). The cell body area was increased in neurons grown on both Fmr1-/- and WT astrocytes 14 DIV, and only slightly so at 21 DIV. Once again, there was no significant difference in this morphological parameter between neurons grown on Fmr1-/- or WT astrocytes at 14 DIV (Fmr1-/-, 242.27 ± 6.45; WT, 246.02 ± 6.66; p = 0.840; Mann Whitney U = 11098.00; F = -0.202) or 21 DIV (Fmr1-/-, 245.13 ± 9.44; WT, 268.05 ± 11.08; p = 0.228; Mann Whitney U = 10344.50; F = -1.205).
The area of the dendritic arbor was significantly decreased in neurons grown on Fmr1-/- astrocytes compared to those grown on WT astrocytes at both 7 DIV (Fmr1-/-, 12373.57 ± 654.79; WT, 17800.08 ± 1038.79; p = 0.000; Mann Whitney U = 8278.00; F = -3.956) and 14 DIV (Fmr1-/-, 8116.14 ± 1126.15; WT, 23209.23 ± 2153.68; p = 0.000; Mann Whitney U = 6001.00; F = -6.987) (Figure 4d). The area of the dendritc arbor increased with time in culture for neurons grown on WT astrocytes. At 21 DIV the area of the dendritic arbor of neurons grown on Fmr1-/- astrocytes also increased, and was comparable to that of the neurons grown on WT astrocytes. The difference was not significant at this point (21 DIV) in culture (Fmr1-/-, 30192.00 ± 1995.85; WT, 31900.05 ± 2020.96; p = 0.539; Mann Whitney U = 10789.00; F = -0.614).
Therefore, by the morphological parameters evaluated in these experiments, it appears that the growth of the neurons early in development (i.e., 7 DIV) is altered when grown on Fmr1-/- astrocytes, but these abnormal characteristics disappear with time. By 14 DIV, three out of four of the morphological characteristics we studied were no longer significantly altered in neurons grown on Fmr1-/- astrocytes. The last parameter, the area of the dendritic arbor, had also reached levels comparable to values seen in neurons grown with WT astrocytes by 21 DIV.
Excitatory Synapse Analysis
Therefore, similar to the morphological characteristics we evaluated, it appears that the abnormal number of synapses found at 7 DIV and 14 DIV on neurons grown with Fmr1-/- astrocytes is brought to levels comparable to normal by 21 DIV.
In this study we used a co-culture procedure in which normal primary hippocampal neurons were co-cultured with normal or Fmr1-/- astrocytes for up to 21 days in vitro in order to investigate the possibility of an astrocyte-mediated delay in hippocampal neuron development. We evaluated the changes in neuron dendritic arbor morphology and excitatory synapse expression at 7, 14 and 21 DIV. We found that both the morphological parameters and the synaptic protein expression approached normal levels by 21 DIV, with three of four morphological parameters approaching normal at 14 DIV. Our results suggest that Fmr1-/- astrocytes do not completely prevent normal hippocampal neuron growth, but delay it.
The morphological results presented herein are consistent with our previously reported results for the effects of Fmr1 -/- astrocytes on normal primary hippocampal neurons at 7 DIV . This finding is further supported by the earlier studies done by Lee et al. (2003). Consistent with our results, they described an increase in dendritic branching in neurons from mice lacking the Drosophila dfmr1 gene . However, the results of the present synaptic protein expression analysis at 7DIV, is different from the synaptic protein analysis at 7 DIV of that same series of experiments. This difference could be due to the modifications of the experimental design in the present studies. First, in this study we used synapsin as our pre-synaptic protein antigen. While we would not expect that there would be a difference in the number of pre-synaptic puncta identified by the synapsin antibody versus the previously used synaptophysin antibody, this difference should be noted. Second, in the previous report we evaluated the pre- and post synaptic proteins independently whereas in the present experiments we report the co-localization of the pre-and post-synaptic proteins. It is in fact possible that the number of pre- or post- synaptic protein puncta does not correlate in a positive direction with the number of synapses. If that were the case there could be a decrease in the numbers of pre- and post-synaptic puncta independently, but there could be an increase in the number of co-localized puncta. Third, and most importantly, here we report the synaptic protein expression in segments of dendrites taken from neuron networks, whereas in the previous paper we focused on the absolute numbers of pre- and post-synaptic puncta per isolated neuron. It could be expected that synapse number will vary when comparing neural networks with isolated neurons.
Dendritic arborization is delayed in neurons grown with Fmr1-/- astrocytes
The results presented here support the idea that hippocampal neurons grown with Fmr1-/- astrocytes reach normal maturity, but are delayed in the process. At 7 DIV the neurons grown on Fmr1-/- astrocytes had significantly different cell measurements from the neurons grown on WT astrocytes for all of the parameters we measured. However, by 21 DIV those neurons had morphological measurements that closely resembled those of neurons grown on normal astrocytes.
During development the growth of dendritic arbors is a highly choreographed dynamic balance between phases of extension and retraction. Cues that regulate the initiation and promote dendritic arbor development are equally as important as those that stop its elaboration . There is compelling evidence suggesting that dendritic arborization is regulated by both intrinsic and extrinsic signals. Astrocytes are known to provide a number of molecules that have been shown to be involved in the growth and maturation of dendritic arbors [1–3].
In the early stages of development the neurons grown on Fmr1-/- astrocytes appear to be in a branching mode of growth, rather than a mode dominated by arbor extension. This suggests that the dendritic arborization is altered in a manner that would interfere with the normal appropriate wiring of the hippocampal circuits. In 2001, Cline suggested that mechanisms that enhance dendritic arbor complexity have the potential to affect the integrative properties and firing characteristics of a neuron . Neurons with more densely branched arbors may receive greater numbers of synaptic input that may affect the manner in which convergent inputs influence the neuron . Astrocytes are known to provide cues that can alter the development of dendritic arbors [2, 3, 30]. Here we show that astrocytes induce increased branching in the early stages of development of hippocampal neuron dendritic arbors in vitro. Thus, there is the possibility that astrocytes induce an increase in branching in the early development of hippocampal neurons in FXS, resulting in the alteration of the signaling properties of the neurons. In turn, this may affect key developmental stages when initial neural networks are being established. These alterations could contribute to the underlying abnormal neurobiology, and therefore the clinical deficiencies observed in FXS.
In addition, it is possible that astrocytes from an Fmr1-/- animal may be unable to appropriately regulate the establishment of the receptive field margins. Under normal conditions there are "stop" signals that inhibit the expansion of dendrites beyond the normal receptive field of the arbor . Although poorly understood, some of these cues are known to originate in a contact dependent manner from the dendrites of adjacent neurons, and from contact independent means via secreted molecules (reviewed in ). Astrocytes present a number of signals that mediate other aspects of dendrite growth and elaboration and therefore it is possible that astrocytes may also play a role in dendritic tiling. In FXS, the 'diseased' astrocytes may inhibit the expansion of the arbor to an abnormal extent, reducing the size of the area of coverage. At later stages in development, other cues could help mediate these adverse effects, and enable the extension of the arbor. However, during that early period of inhibited expansion, irreversible damage may have occurred, thereby preventing the establishment of local circuits in a timely manner necessary for normal neural network maturation. These alterations that develop early in the dendritic arbor could contribute to the underlying abnormal neurobiology, and result in cognitive impairments.
Excitatory synapse formation is delayed in neurons grown with Fmr1-/- astrocytes
The findings of this study suggest that the growth of hippocampal neurons with Fmr1-/- astrocytes impedes the appropriate timing of excitatory synaptic development. At 7 DIV, neurons grown on Fmr1-/- astrocytes had significantly more excitatory synapses than the neurons grown on WT astrocytes. However, by 21 DIV the numbers of excitatory synapses in neurons grown on Fmr1-/- astrocytes were equal to the quantity seen in neurons under normal conditions.
The formation of mature synapses is a dynamic process with a continuous fluctuation between synapses being formed and unwanted synapses being eliminated . Therefore at any time the number of synapses observed can be considered to be the net result of the number of new synapses formed and those being eliminated. At 7 DIV neurons grown on Fmr1-/- astrocytes have a significantly greater number of synapses than neurons grown on WT astrocytes. Perhaps at 7 DIV, growth with Fmr1-/- astrocytes promotes an increase in the production of synapses or a decrease the degree of pruning. A number of studies have suggested that many developmental disorders are caused by a lack of pruning early in development. Our findings therefore support a lack of appropriate synaptic pruning early in development as a potential contributor to the neurological abnormalities seen in FXS.
We found an abnormally high net number of excitatory synapses being maintained in neurons grown on Fmr1-/- astrocytes at 7 DIV, when compared to neurons grown on WT astrocytes. With time, the difference between the net number maintained in the neurons grown on Fmr1-/- astrocytes and those grown on WT astrocytes decreased, until 21 DIV at which point there is no longer a significant difference. The neurons grown on Fmr1-/- astrocytes have reached a stage of maturity at which their net production of excitatory synapses equals that of neurons grown under normal conditions. Still, there is a possibility that the abnormal early stages of development could play a major role in the ability of neurons to later integrate and transmit information effectively. Abnormal synapses may have been formed alongside atypical local neural networks, and these early alterations may negatively affect the neural circuitry of the region in the long run.
However, from the findings of this study we cannot make conclusions about synapse maturity. It is possible that the increase in synapses observed in the neurons grown on Fmr1-/- astrocytes reflects an increased number of immature synapses. Given that the dendritic spine is the site for the majority of excitatory synapses, this finding would be in agreement with numerous studies that identified neurons in Fragile X with an abnormally high number of immature dendritic spines. The methods used in the current study did not permit the assessment of alterations in dendritic spine morphology.
The development of the CNS is a highly organized process requiring the establishment of correct connectivity with specific target cells. The creation of appropriate neural networks requires an intimate coupling of dendritic arborization and synaptogenesis, perfectly timed to promote the normal circuitry underlying normal neurological function. Individuals with FXS syndrome suffer a diverse range of cognitive impairments. Most research has focused on the effects of a lack of FMRP in neurons, and its implications for the underlying neurobiology of FXS. Knowing that astrocytes contribute to the abnormal neurobiology of this disorder, the current results should promote new therapeutic avenues in the treatment of FXS and related autistic disorders.
Using a co-culture system of neurons seeded on astrocytes, we demonstrated that hippocampal neurons showed delays in dendritic growth patterns and also in the expression of excitatory synapses when interfaced with astrocytes that do not express FMRP. This study reinforces the importance of astrocytes in the regulation of normal neuronal development and in the prevention of an altered dendrite phenotype that characterizes Fragile X and autism. Future experiments will focus on differential expression of astrocyte secreted factors and the role of direct neuronal-astrocyte cell contact in the altered developmental sequences we observed in our tissue culture paradigm.
This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Fragile X Research Foundation of Canada.
- Powell EM, Geller HM: Dissection of astrocyte-mediated cues in neuronal guidance and process extension. Glia. 1999, 26 (1): 73-83. 10.1002/(SICI)1098-1136(199903)26:1<73::AID-GLIA8>3.0.CO;2-S.View ArticlePubMedGoogle Scholar
- Banker GA: Trophic interactions between astroglial cells and hippocampal neurons in culture. Science. 1980, 209 (4458): 809-810. 10.1126/science.7403847.View ArticlePubMedGoogle Scholar
- Barres BA: The mystery and magic of glia: a perspective on their roles in health and disease. Neuron. 2008, 60 (3): 430-440. 10.1016/j.neuron.2008.10.013.View ArticlePubMedGoogle Scholar
- Pfrieger FW, Barres BA: Synaptic efficacy enhanced by glial cells in vitro. Science. 1997, 277 (5332): 1684-1687. 10.1126/science.277.5332.1684.View ArticlePubMedGoogle Scholar
- Ullian EM, Sapperstein SK, Christopherson KS, Barres BA: Control of synapse number by glia. Science. 2001, 291 (5504): 657-661. 10.1126/science.291.5504.657.View ArticlePubMedGoogle Scholar
- Maezawa I, Swanberg S, Harvey D, LaSalle JM, Jin LW: Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J Neurosci. 2009, 29 (16): 5051-5061. 10.1523/JNEUROSCI.0324-09.2009.PubMed CentralView ArticlePubMedGoogle Scholar
- Allen NJ, Barres BA: Neuroscience: Glia - more than just brain glue. Nature. 2009, 457 (7230): 675-677. 10.1038/457675a.View ArticlePubMedGoogle Scholar
- Ballas N, Lioy DT, Grunseich C, Mandel G: Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci. 2009, 12 (3): 311-317. 10.1038/nn.2275.PubMed CentralView ArticlePubMedGoogle Scholar
- Hagerman PJ: The fragile X prevalence paradox. J Med Genet. 2008, 45: 498-499. 10.1136/jmg.2008.059055.PubMed CentralView ArticlePubMedGoogle Scholar
- Beckel-Mitchener A, Greenough WT: Correlates across the structural, functional, and molecular phenotypes of fragile X syndrome. Ment Retard Dev Disabil Res Rev. 2004, 10 (1): 53-59. 10.1002/mrdd.20009.View ArticlePubMedGoogle Scholar
- Irwin SA, Galvez R, Greenough WT: Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb Cortex. 2000, 10 (10): 1038-1044. 10.1093/cercor/10.10.1038.View ArticlePubMedGoogle Scholar
- Kaufmann WE, Moser HW: Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex. 2000, 10 (10): 981-991. 10.1093/cercor/10.10.981.View ArticlePubMedGoogle Scholar
- Irwin SA, Patel B, Idupulapati M, Harris JB, Crisostomo RA, Larsen BP, Kooy F, Willems PJ, Cras P, Kozlowski PB, et al, et al.: Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet. 2001, 98 (2): 161-167. 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B.View ArticlePubMedGoogle Scholar
- Kremer EJ, Pritchard M, Lynch M, Yu S, Holman K, Baker E, Warren ST, Schlessinger D, Sutherland GR, Richards RI: Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science. 1991, 252 (5013): 1711-1714. 10.1126/science.1675488.View ArticlePubMedGoogle Scholar
- Bakker C, Verheij C, Willemsen R, van der Helm R, Oerlemans F, Vermey M, Bygrave A, Hoogeveen A, Oostra B, Reyniers E, et al, et al.: Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell. 1994, 78 (1): 23-33.Google Scholar
- Qin M, Kang J, Smith CB: Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA. 2002, 99 (24): 15758-15763. 10.1073/pnas.242377399.PubMed CentralView ArticlePubMedGoogle Scholar
- Chen L, Toth M: Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience. 2001, 103 (4): 1043-1050. 10.1016/S0306-4522(01)00036-7.View ArticlePubMedGoogle Scholar
- Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weiler IJ, Greenough WT: Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci USA. 1997, 94 (10): 5401-5404. 10.1073/pnas.94.10.5401.PubMed CentralView ArticlePubMedGoogle Scholar
- Nimchinsky EA, Oberlander AM, Svoboda K: Abnormal development of dendritic spines in FMR1 knock-out mice. J Neurosci. 2001, 21 (14): 5139-5146.PubMedGoogle Scholar
- Pacey LK, Doering LC: Developmental expression of FMRP in the astrocyte lineage: implications for fragile X syndrome. Glia. 2007, 55 (15): 1601-1609. 10.1002/glia.20573.View ArticlePubMedGoogle Scholar
- Jacobs S, Doering LC: Astrocytes prevent abnormal development in the Fragile X mouse. J Neurosci. 2010, 30 (12): 4508-4514. 10.1523/JNEUROSCI.5027-09.2010.View ArticlePubMedGoogle Scholar
- Jacobs S, Doering LC: Primary dissociated astrocyte and neuron co-culture. Protocols for Neural Cell Culture. Edited by: Doering LC. 2009, New York: Humana Press, 269-284. 10.1007/978-1-60761-292-6_16. 4View ArticleGoogle Scholar
- Narro ML, Yang F, Kraft R, Wenk C, Efrat A, Restifo LL: NeuronMetrics: software for semi-automated processing of cultured neuron images. Brain Res. 2007, 1138: 57-75. 10.1016/j.brainres.2006.10.094.PubMed CentralView ArticlePubMedGoogle Scholar
- Christopherson KS, Ullian EM, Stokes CC, Mullowney CE, Hell JW, Agah A, Lawler J, Mosher DF, Bornstein P, Barres BA: Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell. 2005, 120 (3): 421-433. 10.1016/j.cell.2004.12.020.View ArticlePubMedGoogle Scholar
- Riederer B, Matus A: Differential expression of distinct microtubule-associated proteins during brain development. Proc Natl Acad Sci USA. 1985, 82 (17): 6006-6009. 10.1073/pnas.82.17.6006.PubMed CentralView ArticlePubMedGoogle Scholar
- Greengard P, Valtorta F, Czernik AJ, Benfenati F: Synaptic vesicle phosphoproteins and regulation of synaptic function. Science. 1993, 259 (5096): 780-785. 10.1126/science.8430330.View ArticlePubMedGoogle Scholar
- El-Husseini AE, Schnell E, Chetkovich DM, Nicoll RA, Bredt DS: PSD-95 involvement in maturation of excitatory synapses. Science. 2000, 290 (5495): 1364-1368.PubMedGoogle Scholar
- Lee A, Li W, Xu K, Bogert BA, Su K, Gao FB: Control of dendritic development by the Drosophila fragile X-related gene involves the small GTPase Rac1. Development. 2003, 130 (22): 5543-5552. 10.1242/dev.00792.View ArticlePubMedGoogle Scholar
- Cline HT: Dendritic arbor development and synaptogenesis. Curr Opin Neurobiol. 2001, 11 (1): 118-126. 10.1016/S0959-4388(00)00182-3.View ArticlePubMedGoogle Scholar
- Powell EM, Meiners S, DiProspero NA, Geller HM: Mechanisms of astrocyte-directed neurite guidance. Cell Tissue Res. 1997, 290 (2): 385-393. 10.1007/s004410050945.View ArticlePubMedGoogle Scholar
- Gao FB: Molecular and cellular mechanisms of dendritic morphogenesis. Curr Opin Neurobiol. 2007, 17 (5): 525-532. 10.1016/j.conb.2007.08.004.PubMed CentralView ArticlePubMedGoogle Scholar
- Puro DG, De Mello FG, Nirenberg M: Synapse turnover: the formation and termination of transient synapses. Proc Natl Acad Sci USA. 1977, 74 (11): 4977-4981. 10.1073/pnas.74.11.4977.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.